Pulse pressure respiratory variation in experimental hemorrhage and resuscitation

Autor: Westphal, GA, Poli de Figueiredo, LF, Paoli de Almeida, DP, Garrido, AG, Rocha e Silva, M

Publikováno v: Critical Care

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmc_________::1e8e2c3ee38c04ae5ef58cb156f65068
http://europepmc.org/articles/PMC4097499

Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series.

Autor: Mendes-de-Almeida DP; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Department of Hematology, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Research Center, Instituto Nacional de Câncer, Rio de Janeiro, Brazil., Mouta Nunes de Oliveira P; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Bertollo Gomes Porto V; General Coordination of the National Immunization Program, Brazilian Ministry of Health, Brasília, Distrito Federal, Brazil., Saraiva Pedro R; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Takey PRG; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Lignani LK; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Vitiello Teixeira G; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Pereira TDS; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Abreu DL; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Xavier JR; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Castro TDM; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Melo de Amorim Filho L; Arthur de Siqueira Cavalcanti State Institute of Hematology (HEMORIO), Rio de Janeiro, Brazil., Sousa Maia ML; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2023 Oct 31; Vol. 7 (8), pp. 102243. Date of Electronic Publication: 2023 Oct 31 (Print Publication: 2023).

A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis.

Autor: Mendes-de-Almeida DP; Department of Hematology, Evandro Chagas National Institute of Infectious Diseases, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.; Research Center, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Kehdy FSG; Laboratório de Hanseníase, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil., Martins-Gonçalves R; Laboratory of Immunopharmacology, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil., Bokel J; Department of Hematology, Evandro Chagas National Institute of Infectious Diseases, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.; Onco-Hematology Unit, Clínica São Vicente, Rio de Janeiro, Brazil., Grinsztejn E; Department of Medicine, Hematology and Oncology Division, University Hospitals, Case Western University, Cleveland, OH, United States., Mouta Nunes de Oliveira P; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil., Maia MLS; Department of Medical Affairs, Clinical Studies, and Post-Registration Surveillance (DEAME), Institute of Technology in Immunobiologicals/Bio-Manguinhos, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil., Hoagland B; Laboratory of Clinical Research on STD/AIDS, Evandro Chagas National Institute of Infectious Diseases Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil., Wagner Cardoso S; Laboratory of Clinical Research on STD/AIDS, Evandro Chagas National Institute of Infectious Diseases Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil., Grinsztejn B; Laboratory of Clinical Research on STD/AIDS, Evandro Chagas National Institute of Infectious Diseases Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil., Siqueira MM; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil., Kurtz P; Intensive Care Department, Instituto D'Or de Pesquisa e Ensino, Rio de Janeiro, Brazil., Bozza PT; Laboratory of Immunopharmacology, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil., Garcia CC; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.; Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte, Brazil.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 May 19; Vol. 10, pp. 1189320. Date of Electronic Publication: 2023 May 19 (Print Publication: 2023).

GATA2 variants in patients with non-tuberculous mycobacterial or fungal infections without known immunodeficiencies.

Autor: Mendes-de-Almeida DP; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil; Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil; University of Minnesota, Minneapolis, MN, USA. Electronic address: daniela.almeida@ini.fiocruz.br., Andrade FG; Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil., Dos Santos-Bueno FV; Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil., Saraiva Freitas DF; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil., Soares-Lima SC; Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil., Zancopé-Oliveira RM; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil., Pombo-de-Oliveira MS; Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.

Publikováno v: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2023 Apr-Jun; Vol. 45 (2), pp. 211-216. Date of Electronic Publication: 2022 Mar 06.

Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.

Autor: Mouta Nunes de Oliveira P; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil. Electronic address: Patricia.mouta@bio.fiocruz.br., Mendes-de-Almeida DP; Department of Hematology, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil; Division of Molecular Carcinogenesis, Research Center, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil; Division of Epidemiology, Department of Pediatrics, University of Minnesota, Minneapolis, United States of America., Bertollo Gomes Porto V; General Coordination of the National Immunization Program/National Immunization Program/ Brazilian Ministry of Health, Brazil., Crespo Cordeiro C; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Vitiello Teixeira G; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Saraiva Pedro R; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Roberto Gomes Takey P; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Kegele Lignani L; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Reis Xavier J; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Cardoso Doria da Gama V; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Amorim Filho L; Hemorio , Rio de Janeiro, Brazil., Emoingt Furtado B; AstraZeneca Brasil, Brazil., Santa Maria A; AstraZeneca Brasil, Brazil., Dahrug Barros T; General Coordination of the National Immunization Program/National Immunization Program/ Brazilian Ministry of Health, Brazil., Neves Waite Freitas L; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Dos Santos Pereira T; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Lima Abreu D; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Bernardes Ramos M; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Gabe C; Doctoral Program in Medicine at the Faculty of Medicine of the University of São Paulo, Brazil., Arnold D; McMaster Platelet Immunology Laboratory, Canada., William Smith J; McMaster Platelet Immunology Laboratory, Canada., Nazy I; McMaster Platelet Immunology Laboratory, Canada., Lourdes de Sousa Maia M; Institute of Technology in Immunobiologicals/Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil.

Publikováno v: Vaccine [Vaccine] 2022 Aug 05; Vol. 40 (33), pp. 4788-4795. Date of Electronic Publication: 2022 Jun 16.